UA26845C2 - Похідhі пептидів, що є аhтагоhістами речовиhи р та hейрокіhіhу а - Google Patents

Похідhі пептидів, що є аhтагоhістами речовиhи р та hейрокіhіhу а

Info

Publication number
UA26845C2
UA26845C2 UA5010972A UA5010972A UA26845C2 UA 26845 C2 UA26845 C2 UA 26845C2 UA 5010972 A UA5010972 A UA 5010972A UA 5010972 A UA5010972 A UA 5010972A UA 26845 C2 UA26845 C2 UA 26845C2
Authority
UA
Ukraine
Prior art keywords
neurokinin
antagonists
peptides
derivatives
substance
Prior art date
Application number
UA5010972A
Other languages
English (en)
Russian (ru)
Inventor
Тохру КІHО
Мотоакі HІСІКАВА
Масамі ЕЗАКІ
Суміо КІЙОТО
Original Assignee
Фудзісава Фармасьютікал Ко., Лтд
Фудзисава Фармасьютикал Ко., Лтд
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фудзісава Фармасьютікал Ко., Лтд, Фудзисава Фармасьютикал Ко., Лтд filed Critical Фудзісава Фармасьютікал Ко., Лтд
Publication of UA26845C2 publication Critical patent/UA26845C2/uk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Предметом винаходу є похідні пептидів та їх фармацевтично прийнятні солі. Ці речовини є антагоністами речовини Р та нейрокініну А.
UA5010972A 1988-04-05 1989-04-04 Похідhі пептидів, що є аhтагоhістами речовиhи р та hейрокіhіhу а UA26845C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807921A GB8807921D0 (en) 1988-04-05 1988-04-05 Ws-9326 & its derivatives

Publications (1)

Publication Number Publication Date
UA26845C2 true UA26845C2 (uk) 1999-12-29

Family

ID=10634574

Family Applications (1)

Application Number Title Priority Date Filing Date
UA5010972A UA26845C2 (uk) 1988-04-05 1989-04-04 Похідhі пептидів, що є аhтагоhістами речовиhи р та hейрокіhіhу а

Country Status (20)

Country Link
EP (1) EP0336230B1 (uk)
JP (1) JP2551142B2 (uk)
KR (1) KR0132567B1 (uk)
CN (1) CN1037857C (uk)
AT (1) ATE148890T1 (uk)
AU (1) AU627453B2 (uk)
CA (1) CA1335662C (uk)
DE (1) DE68927759T2 (uk)
DK (1) DK161789A (uk)
ES (1) ES2097736T3 (uk)
FI (1) FI102547B1 (uk)
GB (1) GB8807921D0 (uk)
GR (1) GR3023353T3 (uk)
HU (1) HU204853B (uk)
IL (1) IL89734A (uk)
NO (1) NO177714C (uk)
PH (1) PH30960A (uk)
RU (2) RU1826970C (uk)
UA (1) UA26845C2 (uk)
ZA (1) ZA892188B (uk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0360390A1 (en) * 1988-07-25 1990-03-28 Glaxo Group Limited Spirolactam derivatives
CA2017156A1 (en) * 1989-06-02 1990-12-02 Sotoo Asakura Preparation of fr115224 substance for parenteral administration
FR2666335B1 (fr) 1990-09-05 1992-12-11 Sanofi Sa Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69114117T2 (de) * 1990-12-21 1996-03-21 Fujisawa Pharmaceutical Co Neue Verwendung von Peptidderivat.
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5830854A (en) * 1992-12-14 1998-11-03 Merck Sharp & Dohme, Limited Method of treating cystic fibrosis using a tachykinin receptor antagonist
WO1994020126A1 (en) * 1993-03-03 1994-09-15 Fujisawa Pharmaceutical Co., Ltd. Use of peptides for the manufacture of a medicament
FR2728169A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2728166A1 (fr) 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
FR2728165A1 (fr) 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2741262B1 (fr) 1995-11-20 1999-03-05 Oreal Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
UA105182C2 (uk) 2008-07-03 2014-04-25 Ньюрексон, Інк. Бензоксазини, бензотіазини і споріднені сполуки, що мають інгібуючу nos активність

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4803261A (en) * 1986-06-27 1989-02-07 The Administrators Of The Tulane Educational Fund Method for synthesizing a peptide containing a non-peptide
JPS6424156A (en) * 1987-07-17 1989-01-26 Yanmar Diesel Engine Co Air-fuel ratio control device for gas engine
JP2570670B2 (ja) * 1987-12-28 1997-01-08 味の素株式会社 トキソプラズマ増殖抑制剤
GB8802229D0 (en) * 1988-02-02 1988-03-02 Fujisawa Pharmaceutical Co Ws-9326 & its derivatives

Also Published As

Publication number Publication date
ZA892188B (en) 1989-11-29
JP2551142B2 (ja) 1996-11-06
EP0336230A3 (en) 1991-07-17
HU204853B (en) 1992-02-28
GB8807921D0 (en) 1988-05-05
KR0132567B1 (ko) 1998-04-14
IL89734A (en) 1994-05-30
DE68927759D1 (de) 1997-03-27
CN1037857C (zh) 1998-03-25
NO891389L (no) 1989-10-06
DK161789A (da) 1989-10-06
RU2043365C1 (ru) 1995-09-10
GR3023353T3 (en) 1997-08-29
JPH02204499A (ja) 1990-08-14
NO177714C (no) 1995-11-08
DK161789D0 (da) 1989-04-04
FI102547B (fi) 1998-12-31
HUT49631A (en) 1989-10-30
FI891581A (fi) 1989-10-06
FI102547B1 (fi) 1998-12-31
ATE148890T1 (de) 1997-02-15
AU627453B2 (en) 1992-08-27
RU1826970C (ru) 1993-07-07
NO177714B (no) 1995-07-31
EP0336230A2 (en) 1989-10-11
EP0336230B1 (en) 1997-02-12
NO891389D0 (no) 1989-04-03
DE68927759T2 (de) 1997-06-19
FI891581A0 (fi) 1989-04-03
AU3239789A (en) 1989-10-12
CN1036795A (zh) 1989-11-01
KR890016061A (ko) 1989-11-28
PH30960A (en) 1997-12-23
CA1335662C (en) 1995-05-23
ES2097736T3 (es) 1997-04-16
IL89734A0 (en) 1989-09-28

Similar Documents

Publication Publication Date Title
NL194828B (nl) Somatostatinepeptiden, alsmede dergelijke somatostatinepeptiden bevattende farmaceutische preparaten.
DK1036059T3 (da) Adamantanderivater
DK654589A (da) Heterocykliske derivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
EE200000320A (et) Uudsed ühendid
EE9400455A (et) Peptiidi derivaadid, nende valmistamise protsess, neid sisaldavad ravimpreparaadid ja nende kasutamine
DE68905224T2 (de) Transendoskopische implantatkapsel.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
MX9203602A (es) Administracion iontoforetica mejorada de farmacos.
UA26845C2 (uk) Похідhі пептидів, що є аhтагоhістами речовиhи р та hейрокіhіhу а
FI893340A0 (fi) Foerfarande foer att erhaolla farmaceutiska sammansaettningar foer att hindra smittbara koenssjukdomar.
NO305906B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
NO882897D0 (no) Avleveringssystem for legemidler.
EE9400326A (et) Opioidpeptiidi analoogid, nende valmistamise protsess ja neid sisaldavad ravimpreparaadid
EP0617621A4 (en) CENTRAL CHOLECYSTOKININ ANTAGONISTS HAVING PHARMACEUTICAL EFFECTIVENESS.
DK642588A (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK13089A (da) Substituerede 5,6,7,8-tetrahydro-4h-thieno-(2,3-d)azepin-forbindelser, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
NO892764L (no) Medikamentell administreringsform for droevtyggere.
NO306113B1 (no) Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler
FI905236A0 (fi) Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
NO904416D0 (no) Nye alkylfosfono- og fosfoseriner, fremgangsmaate for fremstilling derav samt farmasoeytiske forbindelser.
DK469189A (da) Substituerede thienopyraner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DE68907392T2 (de) Dysmnesie modifizierende Arzneimittel.
FI901876A0 (fi) Ofullstaendiga hepadnavirus, vaccin producerande cellinjer samt terapi av leversjukdomar.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.